Researchers’ Statement (8/10)
“Most of those vaccinated were between 20 and 59 years old, and the largest number of doses were administered in France,” the researchers explained, specifying that the vaccines came from Pfizer, Moderna, and AstraZeneca. These results did not reassure healthcare professionals, let alone patients.
Guillain-Barré Syndrome and Venous Thrombosis (9/10)
Researchers observed an increase in cases of Guillain-Barré syndrome and cerebral venous thrombosis after the administration of the first dose of the AstraZeneca vaccine. Guillain-Barré syndrome is primarily characterized by muscle weakness, while venous thrombosis is the formation of a blood clot in a vein, obstructing blood flow to the rest of the body. French basketball player Victor Wembanyama suffered from this condition a few months ago, which forced him to end his season.

Further research is needed (10/10).
Moreover, all vaccines significantly increased the risk of myocarditis and pericarditis (inflammation of the myocardium, the muscle responsible for heart contraction and circulation throughout the body). “Other problems have been identified and require further investigation,” the review states. The researchers emphasize that further research is needed to determine the link between the vaccine and these side effects.

Faced with this alarming situation, COVID-19 vaccines were developed urgently. After nearly five years of observation and analysis, we now know the side effects of the various vaccines received.

Many questions remain unanswered (4/10)